Cargando…

P1202: INTENDED USE OF GLUCARPIDASE IN PATIENTS WITH CENTRAL NERVOUS SYSTEM LYMPHOMA AND IMPAIRED RENAL FUNCTION – THE VALIDATE STUDY

Detalles Bibliográficos
Autores principales: Liebig, S., Burock, S., Merz, I., Knörnschild, F., Kießling, P., Kappert, K., Keller, U., Schwartz, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430489/
http://dx.doi.org/10.1097/01.HS9.0000847672.21099.b9
_version_ 1784779782946291712
author Liebig, S.
Burock, S.
Merz, I.
Knörnschild, F.
Kießling, P.
Kappert, K.
Keller, U.
Schwartz, S.
author_facet Liebig, S.
Burock, S.
Merz, I.
Knörnschild, F.
Kießling, P.
Kappert, K.
Keller, U.
Schwartz, S.
author_sort Liebig, S.
collection PubMed
description
format Online
Article
Text
id pubmed-9430489
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94304892022-08-31 P1202: INTENDED USE OF GLUCARPIDASE IN PATIENTS WITH CENTRAL NERVOUS SYSTEM LYMPHOMA AND IMPAIRED RENAL FUNCTION – THE VALIDATE STUDY Liebig, S. Burock, S. Merz, I. Knörnschild, F. Kießling, P. Kappert, K. Keller, U. Schwartz, S. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430489/ http://dx.doi.org/10.1097/01.HS9.0000847672.21099.b9 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Liebig, S.
Burock, S.
Merz, I.
Knörnschild, F.
Kießling, P.
Kappert, K.
Keller, U.
Schwartz, S.
P1202: INTENDED USE OF GLUCARPIDASE IN PATIENTS WITH CENTRAL NERVOUS SYSTEM LYMPHOMA AND IMPAIRED RENAL FUNCTION – THE VALIDATE STUDY
title P1202: INTENDED USE OF GLUCARPIDASE IN PATIENTS WITH CENTRAL NERVOUS SYSTEM LYMPHOMA AND IMPAIRED RENAL FUNCTION – THE VALIDATE STUDY
title_full P1202: INTENDED USE OF GLUCARPIDASE IN PATIENTS WITH CENTRAL NERVOUS SYSTEM LYMPHOMA AND IMPAIRED RENAL FUNCTION – THE VALIDATE STUDY
title_fullStr P1202: INTENDED USE OF GLUCARPIDASE IN PATIENTS WITH CENTRAL NERVOUS SYSTEM LYMPHOMA AND IMPAIRED RENAL FUNCTION – THE VALIDATE STUDY
title_full_unstemmed P1202: INTENDED USE OF GLUCARPIDASE IN PATIENTS WITH CENTRAL NERVOUS SYSTEM LYMPHOMA AND IMPAIRED RENAL FUNCTION – THE VALIDATE STUDY
title_short P1202: INTENDED USE OF GLUCARPIDASE IN PATIENTS WITH CENTRAL NERVOUS SYSTEM LYMPHOMA AND IMPAIRED RENAL FUNCTION – THE VALIDATE STUDY
title_sort p1202: intended use of glucarpidase in patients with central nervous system lymphoma and impaired renal function – the validate study
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430489/
http://dx.doi.org/10.1097/01.HS9.0000847672.21099.b9
work_keys_str_mv AT liebigs p1202intendeduseofglucarpidaseinpatientswithcentralnervoussystemlymphomaandimpairedrenalfunctionthevalidatestudy
AT burocks p1202intendeduseofglucarpidaseinpatientswithcentralnervoussystemlymphomaandimpairedrenalfunctionthevalidatestudy
AT merzi p1202intendeduseofglucarpidaseinpatientswithcentralnervoussystemlymphomaandimpairedrenalfunctionthevalidatestudy
AT knornschildf p1202intendeduseofglucarpidaseinpatientswithcentralnervoussystemlymphomaandimpairedrenalfunctionthevalidatestudy
AT kießlingp p1202intendeduseofglucarpidaseinpatientswithcentralnervoussystemlymphomaandimpairedrenalfunctionthevalidatestudy
AT kappertk p1202intendeduseofglucarpidaseinpatientswithcentralnervoussystemlymphomaandimpairedrenalfunctionthevalidatestudy
AT kelleru p1202intendeduseofglucarpidaseinpatientswithcentralnervoussystemlymphomaandimpairedrenalfunctionthevalidatestudy
AT schwartzs p1202intendeduseofglucarpidaseinpatientswithcentralnervoussystemlymphomaandimpairedrenalfunctionthevalidatestudy